ASX Announcement 19 November 2026 Release of Securities from Escrow ReNerve Limited (ASX: RNV, “ReNerve” or “the Company”), an Australian medical device company developing innovative products for peripheral nerve injury (PNI) repair, advises, in accordance with ASX Listing Rule 3.10A, that...
Release of Securities from Escrow
Filed with ASX · · 2 pages · English
Summary by 6ix AI
ReNerve Limited has announced the release of certain securities from escrow, which includes both mandatory and voluntary shares held by directors and other security holders. The total number of shares being released amounts to a significant figure, and the release will not affect the company's issued share capital. The company acknowledged a delay in notifying the ASX about this release, which was due to an administrative oversight, and has since reviewed its internal procedures to prevent future occurrences.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from ReNerve
- First patient in India receives NervAlign Nerve Cuff
- Quarterly Investor Presentation
- Becoming a substantial holder
- Notification regarding unquoted securities - RNV
- Quarterly Report Webinar
Follow ReNerve into a list and get an email when it puts out news.
Follow ReNerve